Publications

GRK-biased adrenergic agonists for the treatment of type 2 diabetes and obesity

 91
GRK-biased adrenergic agonists for the treatment of type 2 diabetes and obesity

Tags:

Previous Article

Oncogene mutation in colorectal cancer leads to metabolic reprogramming

Next Article

GRK-biased adrenergic agonists for the treatment of type 2 diabetes and obesity

Related Posts

Microglia-specific regulation of lipid metabolism in Alzheimer’s disease revealed by microglial depletion in 5xFAD Mice

Microglia-specific regulation of lipid metabolism in Al...

 24

Iron Deficiency in Adults

Iron Deficiency in Adults

 244

Immunodiagnostic plasma amino acid residue biomarkers detect cancer early and predict treatment response

Immunodiagnostic plasma amino acid residue biomarkers d...

 82